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The ethical approach to evidence-based medicine
Evidence-based medicine has had a major impact on health care 
in the last 30 years. This approach has lead to the critical appraisal 
of therapeutic knowledge. Archie Cochrane, an epidemiologist, 
gave a series of lectures in 1972 regarding his reflections on the 
effectiveness and efficiency of health services.1 He introduced the 
scientific and practical evaluation of treatment modalities and drew 
attention to the possible harm and even iatrogenic injury, as well as 
waste, that can occur if systematic review of interventions is not 
done. 
The concept of evidence-based medicine is defined as “the process 
of systematically finding, appraising, and using contemporaneous 
research findings as the basis for clinical decisions”.2 The practice 
of evidence-based medicine implies the use of individual clinical 
expertise, in combination with a systematic review of the best 
available clinical evidence, which is derived from the relevant 
research.2 The aim is to use the most efficacious interventions in 
the pursuit of quality and quantity of life. This approach is especially 
useful in medical education to teach best clinical practice. 
Evidence-based medicine relies on a hierarchy of evidence, which 
is ranked from absolute proven interventions to the least reliable 
knowledge.3 The process of examining evidence involves multiple 
steps, where the first involves using the available information to 
formulate answerable questions.4 The next step is to search for 
the evidence that can best answer these questions. The third step 
involves the evaluation of the evidence for its importance and validity. 
The clinician thereafter has to integrate these findings with her/his 
clinical expertise and apply it in clinical practice in combination with 
patient values. Continuous evaluation of clinical practice is the last 
ongoing step. There are at present several evidence-based resources 
to assist health care professionals, which provide peer reviewed 
critical appraisal of the best evidence for intervention or treatment, 
of which the Cochrane database is probably the best known. 
The practice of evidence-based medicine usually assists in 
answering two questions, namely what is in the best interest of the 
patient and how should we allocate of health care resources fairly.5 
Evidence-based medicine enables the health care practitioner to 
strive for a clinical ideal, which addresses our ethical responsibility 
towards the best interest of our patient. For this purpose health care 
professionals should pursue health.5 This should be done through 
the pursuit of the most effective ways of achieving health, which is a 
generally acceptable value shared by most people. As professionals 
it is through the pursuit of truth, that we will find most effective 
means to health.5 The premise is in general valid, and most health 
care professionals and researchers will be in agreement with this 
premise. A second premise is that if we pursue evidence-based 
medicine, we shall increase the likelihood of finding truth, which 
shall ensure the provision of the effective means to achieve health.5 
This is not necessarily valid, since the assumptions are that there is 
no bias and that inferences made are not influenced by subjective 
interpretation.
This necessitates an investigation into the potential limitations of 
evidence-based medicine. The first is that there may be the potential 
for bias.5 Funding of health care research is conducted where there 
is commercial value involved for the intervention tested and can in 
this way create bias towards research that will generate good return 
on investment. Furthermore, there can be a technical bias, since we 
may conduct only research where we know how to do it, leaving 
other fields of health care with inadequate or no research. Another 
potential bias is a publication bias, since only positive results are 
published, leaving huge gaps in knowledge regarding interventions 
that did not whave a positive effect on health or, indeed, did harm.
Evidence-based medicine is, furthermore, better suited to secondary 
and tertiary health care, since it deals with a single disease with 
well-defined symptoms and clinical signs. However, in primary 
health care it is not always that easy, since the symptoms are 
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often non-specific, are still evolving and may be related to complex 
psychosocial problems.6 Evidence-based medicine is also not very 
helpful in, especially, rare diseases. At the same time, evidence may 
also be supported poorly by relevant research, since studies may 
contradict each other or may be inconclusive. The application of the 
evidence may also be problematic due to the individual patient with 
confounding health care problems or due to patient value systems. 
The gold standard for evidence-based clinical information is the 
randomised controlled trial (RCT), which is a valuable approach 
to limit the use of worthless treatments and promote effective 
treatments.6,7 Unfortunately RCT is limited to only a section of health 
care management, where interventions are involved in a single entity 
under investigation, leaving other health care sections not being 
examined.6,7 Furthermore, there should be genuine “therapeutic 
equipoise” which implies that the there is a valid doubt about the 
value of the treatment modalities under investigation, which can 
only be answered by the RCT. Again this is difficult to achieve when 
there is great benefit to be obtained if an intervention will have 
great commercial value. Another important factor is that RCT only 
produces the average effect, while some patients may experience 
harm crudely applied. RCT can therefore generate valuable evidence 
for efficacy in the context of a single disease with measurement 
between interventions, but there is a paucity of RCT in primary 
care and other fields of health care.6 This is especially true also for 
rare disease where it is not possible to conduct RCT or where other 
ethical issues are involved, such as lack of informed consent as 
illustrated by GSSI-2 trial, which is widely quoted as evidence due 
to its outcome.8,9 
As already referred to above, the information generated by the RCT 
does not take into account non-quantifiable factors and does not 
provide a framework to integrate such knowledge, such as differences 
in social and cultural backgrounds that may impact on health.6,7 
RCT also relies on the classical theories of statistical inference, 
requiring large sets of data.7 An important argument regarding the 
use of statistical inference is whether this truly provides measures of 
objective probability versus rational subjective interpretation. 
Another limitation of evidence-based medicine relying on RCT is that 
new skills and interventions, which should be developed to ensure 
that there is continuous health care improvement, may be difficult 
to initiate. These very necessary novel interventions will initially not 
be supported by evidence and a good example is pain management 
in neonatology. Pain management per se is difficult to assess, and 
even more so in newborn babies. At the same time the majority of 
therapies are being used off label for these infants, and therefore 
there is no evidence to be derived from the appropriate RCT. This 
leads to the situation that there is little active research into this field, 
which is potentially harmful to neonates. We can conclude that there 
are competing claims that cannot all be resolved by evidence-based 
medicine, i.e. relying on RCT for the evidence. 
Another important negative impact of evidence-based medicine is 
that it may create a barrier to quality health care in the context of 
high demand versus scarce resources. The different stakeholders 
may interpret the evidence differently and their conclusions will not 
be congruent with each other.10 Problematic values in this context 
are justice and quality of life, which are often replaced by more easily 
measured values such as cost and mortality respectively. Resource 
allocation on the basis of evidence-based medicine involves value 
judgements and often a lack of evidence means a lack of value.10 
Government and service providers may use evidence-based medicine 
to the disadvantage of patients when they agree to only fund what 
has been proven by evidence-based medicine, which usually implies 
RCT. This again implies that only conditions that are well researched 
will get access to resources, while other areas where there is little 
or no evidence, will receive no resource allocation.10 If evidence-
based medicine is used for “evidence-based purchasing”, it will 
create a tension between the best interest of the individual versus 
the population .10 
A further problem with evidence-based medicine is that it is doctor-
driven and patients have little influence on the subject matter. Another 
concern is that it only focuses on the evidence for efficacy and not 
on the way the information was obtained. Again the GISSI-2 trial 
is often quoted for proof of efficacy, while the study did not obtain 
informed consent from participants and therefore was conducted not 
respecting patient autonomy.8 
In conclusion evidence-based medicine is probably a simplistic 
solution to inherent complex problems. However, even if there are 
limitations, it is a shared value in the sense that we all want to be 
treated with the best proven intervention and therefore we do expect 
health care professionals to practice their profession by combining 
their individual clinical skill with evidence-based medicine. 
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